Thioredoxin as a therapeutic target in cerebral ischemia.

CONCLUSION: In conclusion, Trx has a potential neuroprotection in cerebral ischemia and may be very promising for clinical therapy of ischemic stroke in the future.
PMID: 30124144 [PubMed - as supplied by publisher]

Source: Current Pharmaceutical Design - August 20, 2018 Category: Drugs & Pharmacology Authors: Zeng XS, Geng WS, Chen L, Jia JJ Tags: Curr Pharm Des Source Type: research